{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:21:22Z","timestamp":1787746882811,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd003333.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000}}],"reference-count":49,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003333.pub4","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T06:52:42Z","timestamp":1749624762000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antiplatelet versus anticoagulation treatment for people with heart failure in sinus rhythm"],"prefix":"10.1002","volume":"2025","author":[{"given":"Monika","family":"Kozie\u0142-Sio\u0142kowska","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science; University of Liverpool and Liverpool Heart & Chest Hospital; Liverpool UK"},{"name":"1st Department of Cardiology and Angiology; Silesian Centre for Heart Diseases; Zabrze Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Shantsila","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science; University of Liverpool and Liverpool Heart & Chest Hospital; Liverpool UK"},{"name":"Department of Primary Care and Mental Health; University of Liverpool; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Shantsila","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science; University of Liverpool and Liverpool Heart & Chest Hospital; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science; University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital; Liverpool UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"10.1002\/14651858.CD003333.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure. The warfarin and antiplatelet therapy in chronic heart failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0735-1097(97)00502-0","article-title":"Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial","volume":"31","author":"Al-Khadra","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0006|cit6","unstructured":"Liu PY Li YH Chen JH Tsai LM A double-blind randomized placebo pilot study comparing aggrenox versus placebo in heart failure patients (ASAP-HF trial) European Journal of Heart Failure 2013 S74"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0007|cit7","first-page":"159","article-title":"A randomized controlled trial of aspirin compared to clopidogrel in patients with heart failure","volume":"35","author":"Parsons","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0008|cit8","first-page":"267","article-title":"The clopidogrel or aspirin in chronic heart failure (CACHE) study","volume":"16","author":"Parsons","year":"2014","journal-title":"European Journal of Heart Failure"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003333.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1388-9842(02)00028-4","article-title":"Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction severe heart failure and left ventricular systolic dysfunction (EPICAL study)","volume":"4","author":"Echemann","year":"2002","journal-title":"European Journal of Heart Failure"},{"issue":"12","key":"10.1002\/14651858.CD003333.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jamaneurol.2021.3828","article-title":"Left ventricular dysfunction among patients with embolic stroke of undetermined source and the effect of rivaroxaban vs aspirin: a subgroup analysis of the NAVIGATE ESUS randomized clinical trial","volume":"78","author":"Merkler","year":"2021","journal-title":"JAMA Neurology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003333.pub4-BIB0013|cit13","first-page":"218A","article-title":"The effect of warfarin on prevalence of stroke in patients with severe heart failure","volume":"21","author":"Falk","year":"1993","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJM199701233360403","article-title":"Ventricular dysfunction and the risk of stroke after myocardial infarction","volume":"336","author":"Loh","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0002-9149(97)00013-1","article-title":"Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure","volume":"79","author":"Dries","year":"1997","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(97)00019-3","article-title":"Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials","volume":"29","author":"Dries","year":"1997","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD003333.pub4-BIB0017|cit17","first-page":"VI194","article-title":"Incidence of thromboembolic events in congestive heart failure","volume":"87","author":"Dunkman","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD003333.pub4-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001925.pub2","article-title":"Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","author":"Aguilar","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10654-010-9520-y","article-title":"Heart failure and the risk of stroke: the Rotterdam Study","volume":"25","author":"Alberts","year":"2010","journal-title":"European Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - II:Maintenance of vascular graft or arterial patency by antiplatelet therapy","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"issue":"9678","key":"10.1002\/14651858.CD003333.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists' Collaboration","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0025|cit25","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2020"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0026|cit26","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"5","key":"10.1002\/14651858.CD003333.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1160\/TH11-03-0168","article-title":"Disease burden and unmet needs for prevention of venous thromboembolism in medically ill patients in Europe show underutilisation of preventive therapies","volume":"106","author":"Khoury","year":"2011","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0735-1097(86)80489-2","article-title":"Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary preventionwith persantine and aspirin","volume":"7","author":"Klimt","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0030|cit30","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH12-08-0578","article-title":"Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis","volume":"108","author":"Lip","year":"2012","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD003333.pub4-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003336.pub3","article-title":"Anticoagulation versus placebo for heart failure in sinus rhythm","author":"Lip","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"36","key":"10.1002\/14651858.CD003333.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD003333.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/1747493019877296","article-title":"Oral anticoagulation versus antiplatelet or placebo for stroke prevention in patients with heart failure and sinus rhythm: systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Ntaios","year":"2019","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"Effects of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjmed.2010.10.014","article-title":"Venous thromboembolism in heart failure: preventable deaths during and after hospitalization","volume":"124","author":"Piazza","year":"2011","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003333.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.54.2.288","article-title":"Stroke in patients with heart failure and reduced left ventricular ejection fraction","volume":"54","author":"Pullicino","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000352058","article-title":"Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial","volume":"36","author":"Pullicino","year":"2013","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0039|cit39","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing summary of findings tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020 Available from https:\/\/training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pcad.2015.09.005","article-title":"Preventing thrombosis to improve outcomes in heart failure patients","volume":"58","author":"Shantsila","year":"2016","journal-title":"Progress in Cardiovascular Diseases"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","author":"The SOLVD Investigators","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"658S","DOI":"10.1378\/chest.114.5_Supplement.658S","article-title":"Antithrombotic therapy in patients with saphenous vein and internal mammaryartery bypass grafts","volume":"114(5 Suppl)","author":"Stein","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.STR.19.4.436","article-title":"Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials","volume":"19","author":"Sze","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD003333.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cardfail.2007.01.009","article-title":"The incidence of ischemic stroke in chronic heart failure: a meta-analysis","volume":"6","author":"Witt","year":"2007","journal-title":"Journal of Cardiac Failure"},{"issue":"2","key":"10.1002\/14651858.CD003333.pub4-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003333","article-title":"Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm","author":"Lip","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003333.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/qjmed\/95.7.461","article-title":"Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review","volume":"95","author":"Lip","year":"2002","journal-title":"QJM"},{"issue":"5","key":"10.1002\/14651858.CD003333.pub4-BIB0048|cit48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003333.pub2","article-title":"Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm","author":"Lip","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003333.pub4-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003333.pub3","article-title":"Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm","author":"Shantsila","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:47:34Z","timestamp":1787744854000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003333.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003333.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}